Health warnings on e-cigarettes effectively discourage vaping and increase intentions to quit, according to a meta-analysis of 24 studies by researchers at the University of North Carolina Lineberger Comprehensive Cancer Center. The study, published in JAMA Internal Medicine on June 2, revealed that warnings about health harms were more impactful than those focusing on addiction, with no unintended consequences like pushing users toward traditional cigarettes.
The meta-analysis, led by Dr. Seth M. Noar and Dr. Youjin Jang, examined data from 22,549 participants with a median age of 28. The warnings tested included text-only messages on packaging, advertisements, and social media posts. Results showed that such warnings heightened perceptions of vaping’s risks and addictiveness, with health-specific warnings—like Canada’s “WARNING: Vaping products release chemicals that may harm your health” proving particularly effective.
Dr. Noar emphasized the importance of rotating multiple warnings to address diverse harms, noting that current U.S. FDA mandates only require a single addiction warning. The study also dispelled concerns that warnings might mislead users into believing e-cigarettes are more harmful than traditional cigarettes.
“This is the first meta-analysis testing the effectiveness of e-cigarette warnings,” said Dr. Noar. “The results highlight the critical role of communicating risks to the public.” Dr. Jang added, “Expanding text warnings to include health hazards is a vital next step for policy.”
The findings underscore the potential of well-designed warnings to curb vaping without unintended misinformation. Future research may explore warnings directly on e-cigarette devices, as discarded packaging often prevents users from seeing them. This study supports broader, rotating warnings to maximize public health impact.
Add comment